Description

CinnoRA Injection (Adalimumab) 40mg/0.8ml – Uses, Dosage, Side Effects & Buy Online in Pakistan

Product Introduction

CinnoRA Injection (Adalimumab) 40mg/0.8ml is an imported prescription biologic medicine containing Adalimumab, a monoclonal antibody that belongs to the class of Tumor Necrosis Factor (TNF-α) inhibitors. It is widely prescribed for the treatment of several chronic autoimmune and inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn’s disease, ulcerative colitis, and hidradenitis suppurativa.

Adalimumab works by blocking Tumor Necrosis Factor-alpha (TNF-α), a protein responsible for excessive inflammation in the body. By reducing abnormal immune activity, CinnoRA Injection (Adalimumab) 40mg/0.8ml helps relieve joint pain, swelling, skin inflammation, and other symptoms associated with autoimmune disorders while improving long-term disease control and quality of life.

Patients looking to buy CinnoRA Injection (Adalimumab) 40mg/0.8ml online in Pakistan should always purchase from a trusted supplier to ensure product authenticity, proper cold-chain storage, and safe handling. Since this is a prescription biologic medicine, treatment should always be initiated and monitored by a qualified healthcare professional.

Product Overview

What is CinnoRA Injection (Adalimumab) 40mg/0.8ml?

CinnoRA Injection (Adalimumab) 40mg/0.8ml is a recombinant monoclonal antibody designed to target and block Tumor Necrosis Factor-alpha (TNF-α), one of the key inflammatory proteins involved in autoimmune diseases. Excess production of TNF-α can cause persistent inflammation that damages joints, skin, and other body tissues.

By specifically inhibiting TNF-α activity, CinnoRA Injection (Adalimumab) 40mg/0.8ml helps control inflammation, reduce disease progression, relieve symptoms, and improve physical function in eligible patients. It is considered one of the most established biologic therapies for moderate to severe autoimmune conditions when conventional treatments are not sufficient.

Because Adalimumab modifies immune system activity, regular medical monitoring is essential throughout treatment to ensure both safety and effectiveness.

How CinnoRA Injection (Adalimumab) 40mg/0.8ml Works

CinnoRA Injection (Adalimumab) 40mg/0.8ml contains Adalimumab, a fully human monoclonal antibody that selectively binds to Tumor Necrosis Factor-alpha (TNF-α).

TNF-α is a naturally occurring inflammatory cytokine that plays a central role in the development of autoimmune diseases. In many inflammatory conditions, excessive TNF-α production leads to chronic pain, swelling, tissue damage, and progressive joint destruction.

After administration, Adalimumab binds directly to TNF-α and prevents it from interacting with its receptors. This action helps:

• Reduce chronic inflammation
• Relieve joint pain and stiffness
• Improve mobility and physical function
• Slow disease progression
• Reduce skin inflammation in psoriasis
• Improve gastrointestinal inflammation in Crohn’s disease and ulcerative colitis
• Protect joints and surrounding tissues from long-term damage

With consistent treatment under specialist supervision, many patients experience significant improvement in symptoms and overall quality of life.

Medical Uses of CinnoRA Injection (Adalimumab) 40mg/0.8ml

Healthcare professionals prescribe CinnoRA Injection (Adalimumab) 40mg/0.8ml for the treatment of several chronic autoimmune and inflammatory diseases.

Rheumatoid Arthritis (RA)

One of the most common uses of CinnoRA Injection (Adalimumab) 40mg/0.8ml is the treatment of moderate to severe rheumatoid arthritis. It helps reduce joint inflammation, relieve pain, slow structural joint damage, and improve physical function.

Psoriatic Arthritis

Adalimumab is also prescribed for adults with psoriatic arthritis, helping control joint symptoms while improving skin lesions associated with psoriasis.

Ankylosing Spondylitis

Patients with ankylosing spondylitis may benefit from Adalimumab therapy to reduce spinal inflammation, improve mobility, and decrease stiffness.

Plaque Psoriasis

For patients with moderate to severe chronic plaque psoriasis, CinnoRA Injection (Adalimumab) 40mg/0.8ml helps reduce skin plaques, itching, redness, and scaling by targeting the underlying inflammatory process.

Crohn’s Disease

Adalimumab is indicated for certain patients with moderate to severe Crohn’s disease who have not responded adequately to conventional therapies.

Ulcerative Colitis

The medicine may also be prescribed to adults with ulcerative colitis to help control intestinal inflammation and maintain remission.

Hidradenitis Suppurativa

In selected patients with moderate to severe hidradenitis suppurativa, Adalimumab can help reduce painful inflammatory nodules and improve skin symptoms.

Benefits of CinnoRA Injection (Adalimumab) 40mg/0.8ml

CinnoRA Injection (Adalimumab) 40mg/0.8ml offers significant therapeutic benefits for patients living with chronic autoimmune and inflammatory diseases. By targeting the underlying cause of inflammation rather than simply relieving symptoms, Adalimumab helps improve long-term disease management and overall quality of life.

Some of the key benefits include:

• Helps reduce inflammation throughout the body.
• Relieves joint pain, swelling, and stiffness.
• Slows the progression of autoimmune diseases.
• Improves physical mobility and daily functioning.
• Reduces skin lesions associated with plaque psoriasis.
• Helps achieve and maintain remission in inflammatory bowel diseases.
• Improves quality of life in patients with chronic inflammatory conditions.
• Decreases the need for long-term corticosteroid therapy in some patients, as determined by a healthcare provider.

Who Can Benefit from CinnoRA Injection (Adalimumab) 40mg/0.8ml?

Healthcare professionals may prescribe CinnoRA Injection (Adalimumab) 40mg/0.8ml for adults and eligible pediatric patients diagnosed with specific autoimmune conditions.

Patients who may benefit include those with:

• Moderate to severe Rheumatoid Arthritis
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Plaque Psoriasis
• Crohn’s Disease
• Ulcerative Colitis
• Hidradenitis Suppurativa
• Certain cases of Juvenile Idiopathic Arthritis (when prescribed by a specialist)

Treatment suitability depends on the patient’s medical history, disease severity, laboratory investigations, and overall clinical condition.

Dosage and Administration

The dosage of CinnoRA Injection (Adalimumab) 40mg/0.8ml varies depending on the medical condition being treated, the patient’s age, body weight, and clinical response. Always follow the exact treatment plan prescribed by your healthcare provider.

General Administration Guidelines

• Administer the injection exactly as prescribed.
• It is given as a subcutaneous injection (under the skin).
• Common injection sites include the abdomen or front of the thigh.
• Rotate injection sites with each dose to reduce skin irritation.
• Avoid injecting into bruised, scarred, red, or damaged skin.
• Never change the dose or treatment schedule without consulting your doctor.

How to Use CinnoRA Injection (Adalimumab) 40mg/0.8ml

Proper administration helps ensure safe and effective treatment.

Before using the injection:

• Remove the prefilled syringe or pen from the refrigerator and allow it to reach room temperature naturally.
• Inspect the solution before use. Do not use it if it appears cloudy, discolored, or contains visible particles.
• Wash your hands thoroughly before administration.
• Clean the injection site using an alcohol swab.
• Inject the medicine according to your healthcare provider’s instructions.
• Dispose of the used syringe or pen safely in an approved sharps container.

Patients should receive proper training from a healthcare professional before self-administering the injection.

Missed Dose

If you miss a scheduled dose of CinnoRA Injection (Adalimumab) 40mg/0.8ml, contact your healthcare provider for guidance. Do not administer a double dose to make up for the missed injection unless specifically instructed by your doctor.

Possible Side Effects of CinnoRA Injection (Adalimumab) 40mg/0.8ml

Like all prescription biologic medicines, CinnoRA Injection (Adalimumab) 40mg/0.8ml may cause side effects. Most are mild to moderate, but serious adverse reactions can occur in some patients.

Common Side Effects

• Injection site redness
• Mild pain or swelling at the injection site
• Headache
• Skin rash
• Nausea
• Upper respiratory tract infections
• Sinus congestion
• Fatigue

Less Common Side Effects

• Increased risk of infections
• Elevated liver enzymes
• Allergic skin reactions
• Dizziness

Serious Side Effects

Seek immediate medical attention if you experience:

• High fever or persistent infection
• Difficulty breathing
• Severe allergic reaction
• Chest pain
• Vision changes
• Persistent cough
• Unusual bruising or bleeding
• Signs of tuberculosis or hepatitis B reactivation

Because Adalimumab affects the immune system, regular medical monitoring is essential throughout treatment.

Warnings and Precautions

Before starting CinnoRA Injection (Adalimumab) 40mg/0.8ml, inform your healthcare provider about your complete medical history.

Special precautions should be taken if you have:

• Active infection
• Tuberculosis (TB)
• Hepatitis B infection
• Congestive heart failure
• Multiple sclerosis or other demyelinating disorders
• Liver disease
• History of cancer
• Diabetes
• Recent vaccinations

Patients should be screened for tuberculosis and hepatitis B before initiating treatment with Adalimumab.

Live vaccines should generally be avoided during treatment unless advised by your healthcare provider.

Drug Interactions

CinnoRA Injection (Adalimumab) 40mg/0.8ml may interact with other medicines that affect the immune system.

Inform your healthcare provider if you are taking:

• Other biologic medicines
• TNF inhibitors
• Abatacept
• Anakinra
• Immunosuppressants
• Methotrexate
• Corticosteroids

Never start or stop any medication without consulting your doctor.

Storage Instructions

Proper storage is essential to maintain the safety, stability, and effectiveness of CinnoRA Injection (Adalimumab) 40mg/0.8ml.

Follow these storage recommendations carefully:

• Store in a refrigerator at 2°C to 8°C.
• Do not freeze the injection.
• Keep the medicine in its original carton to protect it from light.
• Do not shake the prefilled syringe or injection pen.
• Keep away from excessive heat and direct sunlight.
• Store out of the reach of children and pets.
• If the product has expired or has been stored improperly, do not use it and consult your pharmacist for safe disposal.

Frequently Asked Questions (FAQs)

1. What is CinnoRA Injection (Adalimumab) 40mg/0.8ml used for?

CinnoRA Injection (Adalimumab) 40mg/0.8ml is prescribed for autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn’s disease, ulcerative colitis, and hidradenitis suppurativa.

2. How does CinnoRA Injection work?

It contains Adalimumab, a TNF-alpha inhibitor that blocks inflammatory proteins responsible for autoimmune disease activity, helping reduce inflammation and slow disease progression.

3. Is CinnoRA Injection a biologic medicine?

Yes. CinnoRA Injection (Adalimumab) 40mg/0.8ml is a biologic medicine and belongs to the class of TNF-alpha inhibitors.

4. Is a prescription required?

Yes. This medicine is available only with a valid prescription and should be used under the supervision of a qualified healthcare professional.

5. What are the common side effects of Adalimumab?

Common side effects may include injection site reactions, headache, mild infections, skin rash, nausea, and fatigue. Serious infections require immediate medical attention.

6. How should CinnoRA Injection be stored?

Store the injection in a refrigerator at 2°C to 8°C, protect it from light, and never freeze the product.

7. Can I buy CinnoRA Injection online in Pakistan?

Yes. You can buy CinnoRA Injection (Adalimumab) 40mg/0.8ml online in Pakistan from trusted suppliers such as ImpoMedic, ensuring you receive genuine imported medicines with proper storage conditions.

8. Can CinnoRA Injection be self-administered?

Some patients may self-administer the injection after receiving proper training from their healthcare provider. Always follow your doctor’s instructions carefully.

Buy CinnoRA Injection (Adalimumab) 40mg/0.8ml Online in Pakistan

If you are looking to buy CinnoRA Injection (Adalimumab) 40mg/0.8ml online in Pakistan, always choose a trusted supplier that provides 100% genuine imported medicines with proper cold-chain handling.

At ImpoMedic, we are committed to supplying authentic imported specialty medicines sourced from reliable pharmaceutical manufacturers. Every order is handled according to recommended storage standards to help preserve product quality during transportation.

Because CinnoRA Injection (Adalimumab) 40mg/0.8ml is a prescription biologic medicine, it should only be purchased and used under the supervision of a qualified healthcare professional.

Why Choose ImpoMedic?

Finding authentic biologic medicines in Pakistan can be challenging. ImpoMedic aims to provide patients and healthcare professionals with reliable access to genuine imported medicines while maintaining high standards of quality and customer care.

Why customers choose ImpoMedic:

• Genuine imported medicines
• Trusted pharmaceutical sourcing
• Temperature-controlled handling for biologic medicines
• Secure ordering process
• Nationwide delivery across Pakistan
• Professional customer support
• Competitive pricing
• Reliable service for specialty and prescription medicines

Need a trusted source for CinnoRA Injection (Adalimumab) 40mg/0.8ml?

Order from ImpoMedic and get access to genuine imported biologic medicines with reliable nationwide delivery across Pakistan. If you have questions regarding product availability, dosage, or safe administration, our support team is ready to assist you. Always use CinnoRA Injection (Adalimumab) 40mg/0.8ml exactly as prescribed by your healthcare professional.